Santa Cruz Biotechnology features a diverse variety of 26S Proteasome p42A monoclonal antibodies for investigating proteasome function in cellular processes. 26S Proteasome p42A Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).The 26S proteasome is essential for protein degradation and regulation of various cellular functions, including the cell cycle, apoptosis, and responses to oxidative stress. By facilitating the breakdown of ubiquitinated proteins, the 26S proteasome plays a vital role in maintaining cellular homeostasis and regulating protein turnover. Understanding the function of the 26S Proteasome p42A is crucial for elucidating mechanisms underlying numerous diseases, including cancer and neurodegenerative disorders. Researchers can explore protein degradation pathways and their impact on cellular function using specific detection methods. Advanced research techniques allow for detailed analysis of proteasome activity in various biological systems. Investigating 26S Proteasome p42A can reveal new insights into disease mechanisms and potential therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of protein degradation pathways and their implications in human health.